COMMONWEALTH EQUITY SERVICES, LLC - LINEAGE CELL THERAPEUTICS IN ownership

LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 98 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
COMMONWEALTH EQUITY SERVICES, LLC ownership history of LINEAGE CELL THERAPEUTICS IN
ValueSharesWeighting
Q2 2024$48
-32.4%
47,7610.0%0.00%
Q1 2024$71
+36.5%
47,7610.0%0.00%
Q4 2023$52
-18.8%
47,761
-12.3%
0.00%
Q3 2023$64
-12.3%
54,482
+5.8%
0.00%
Q2 2023$73
+1.4%
51,482
+6.2%
0.00%
Q1 2023$72
+26.3%
48,489
-1.0%
0.00%
Q4 2022$57
-99.9%
48,989
+14.0%
0.00%
Q3 2022$48,000
-32.4%
42,990
-5.5%
0.00%
Q2 2022$71,000
+1.4%
45,490
+0.0%
0.00%
Q1 2022$70,000
-25.5%
45,489
+17.8%
0.00%
Q4 2021$94,000
-14.5%
38,629
-12.1%
0.00%
Q3 2021$110,000
-28.6%
43,939
-19.1%
0.00%
Q2 2021$154,000
+36.3%
54,339
+12.4%
0.00%
Q1 2021$113,000
-28.5%
48,325
-46.2%
0.00%
Q4 2020$158,000
+85.9%
89,829
-1.7%
0.00%
Q3 2020$85,000
+14.9%
91,419
+7.0%
0.00%
Q2 2020$74,000
+21.3%
85,419
+14.2%
0.00%
Q1 2020$61,000
+3.4%
74,828
+11.7%
0.00%
Q4 2019$59,000
-47.3%
67,010
-41.4%
0.00%
Q3 2019$112,000114,3580.00%
Other shareholders
LINEAGE CELL THERAPEUTICS IN shareholders Q1 2020
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 34,935,485$52,403,2283.69%
Raffles Associates 1,536,946$2,305,4193.14%
Defender Capital, LLC. 5,136,085$7,704,1282.69%
Prescott General Partners LLC 1,851,851$2,777,7770.22%
DAFNA Capital Management LLC 140,000$210,0000.06%
Beirne Wealth Consulting Services, LLC 45,000$67,5000.05%
CTC Capital Management, LLC 14,100$21,1500.04%
Diametric Capital, LP 50,875$76,3130.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 781,766$1,172,6490.03%
One68 Global Capital, LLC 13,377$20,0660.03%
View complete list of LINEAGE CELL THERAPEUTICS IN shareholders